KK
COGT icon

KLP Kapitalforvaltning’s Cogent Biosciences COGT Stock Holding History

KLP Kapitalforvaltning’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
27,800
+9,300
+50% +$325K ﹤0.01% 1093
2026
Q1 		$712K Buy
18,500
+700
+4% +$25.8K ﹤0.01% 1223
2025
Q4 		$632K Sell
17,800
-1,100
-6% -$30.9K ﹤0.01% 1286
2025
Q3 		$271K Hold
18,900
– – ﹤0.01% 1692
2025
Q2 		$136K Buy
18,900
+7,600
+67% +$42.1K ﹤0.01% 1926
2025
Q1 		$67.7K Hold
11,300
– – ﹤0.01% 2137
2024
Q4 		$88.1K Buy
+11,300
New +$113K ﹤0.01% 2130

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KLP Kapitalforvaltning's COGT Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Cogent Biosciences (COGT) stake by 50% in Q2 2026, buying an estimated $325K and bringing the position to 27,800 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1093.

KLP Kapitalforvaltning first reported a position in COGT in Q4 2024 and has held it in 7 quarters since. 322 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • KLP Kapitalforvaltning held 27,800 shares of Cogent Biosciences worth $1.08M as of Q2 2026.
  • KLP Kapitalforvaltning bought 9,300 Cogent Biosciences shares in Q2 2026, an estimated $325K.
  • Cogent Biosciences made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1093 holding.
  • KLP Kapitalforvaltning first reported a position in Cogent Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 322 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.